December 5, 2005
Martin Bauer North America
Martin BauerNorth America (www.mb-northamerica.com) added xanthosteen 3510 to its line ofmangosteen (Garcinia mangostana)offerings. Xanthosteen 3510 is produced under a pharmaceuticalmanufacturing license for the newly implemented European Union GMPs (goodmanufacturing practices) and is standardized to three separate marker compounds.MB North America also offers mangosteen peel extracts, peel powders and fruitpowders.
You May Also Like
Advancing gender equity in the nutraceutical industrySep 25, 2023
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023